Cervical Adenosquamous Cell Carcinoma Terminated Phase 2 Trials for Ixabepilone (DB04845)

Also known as: Cervical Adenosquamous Carcinoma / Adenosquamous carcinoma of the cervix / Adenosquamous carcinoma of cervix (disorder)

IndicationStatusPhase
DBCOND0034091 (Cervical Adenosquamous Cell Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00924066Ixabepilone to Treat Cervical CancerTreatment